Cyanotoxins at low doses induce apoptosis and inflammatory effects in murine brain cells: Potential implications for neurodegenerative diseases  by Takser, Larissa et al.
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Cyanotoxins  have  been  shown  to  be highly  toxic  for  mammalian  cells,  including  brain  cells.  However,
little  is known  about  their  effect  on  inﬂammatory  pathways.  This  study  investigated  whether  mam-
malian  brain  and  immune  cells  can  be  a target  of certain  cyanotoxins,  at doses  approximating  those  in
the guideline  levels  for drinking  water,  either  alone  or in  mixtures.  We  examined  the  effects on  cellular
viability,  apoptosis  and  inﬂammation  signalling  of  several  toxins  on  murine  macrophage-like  RAW264.7,
microglial  BV-2  and  neuroblastoma  N2a  cell  lines.  We  tested  cylindrospermopsin  (CYN),  microcystin-
LR  (MC-LR),  and  anatoxin-a  (ATX-a),  individually  as  well  as their  mixture.  In  addition,  we studied  the
neurotoxins  -N-methylamino-l-alanine (BMAA)  and  its  isomer  2,4-diaminobutyric  acid  (DAB),  as  well
as the  mixture  of both.  Cellular  viability  was determined  by  the MTT assay.  Apoptosis  induction  was
assessed  by  measuring  the  activation  of caspases  3/7.  Cell  death  and  inﬂammation  are  the  hallmarks  of
neurodegenerative  diseases.  Thus,  our ﬁnal  step  was  to quantify  the  expression  of a  major  proinﬂamma-
tory  cytokine  TNF-  by  ELISA.  Our  results  show  that  CYN,  MC-LR  and  ATX-a,  but not  BMAA  and  DAB,  at
low  doses,  especially  when  present  in  a mixture  at threefold  less  concentrations  than  individual  com-
pounds  are 3–15  times  more  potent  at inducing  apoptosis  and  inﬂammation.  Our results  suggest  that
common  cyanotoxins  at low  doses  have  a potential  to induce  inﬂammation  and  apoptosis  in  immune
and  brain  cells.  Further  research  of  the neuroinﬂammatory  effects  of these  compounds  in  vivo  is  needed
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. Introduction
The quality of drinking water is a major worldwide public health
ssue. A large number of man-made chemicals and naturally occur-
ing toxins have been detected in many drinking water sources.
reshwater cyanobacteria may  accumulate in surface water sup-
lies as “blooms” and may  concentrate on the surface as blue–green
scums”. They produce a range of toxic compounds called cyanotox-
ns that have a deleterious effect on raw water sources [53].
Cyanobacterial blooms are occurring with increasing frequency
orldwide in fresh, brackish and marine water and in North
merica, Europe, Australia, Asia, Africa, Indian and Paciﬁc oceans
10,14,1,49,9,35]. For instance, over the last decade, in Quebec
∗ Corresponding author at: Department of Pediatrics, University of Sherbrooke,
ospital Centre, 3001, 12e Avenue Nord, Sherbrooke, J1H 5N4 Quebec, Canada.
ax: +1 819 564 5398.
E-mail address: denis.gris@usherbrooke.ca (D. Gris).
ttp://dx.doi.org/10.1016/j.toxrep.2015.12.008
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access or cyanotoxins  in drinking  water  and  food.
hed  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY
license  (http://creativecommons.org/licenses/by/4.0/).
(Canada), the number of affected water bodies increased from 34 in
2004 to 119 in 2009 [36,37] and is expected to continue to increase.
Risk management of emerging cyanotoxins in worldwide water
sources is compromised due to insufﬁcient human and experimen-
tal data [11]. And, it is clear that current water quality guidelines,
which focus on individual toxins, do not consider the potential
combined or synergistic effects of mixtures of toxins.
Cyanotoxins are resistant to chemical and biological degrada-
tion and bioaccumulate in the food chain [32,25]. They can be
classiﬁed into three main types according to their mechanism
of action such as hepatotoxins (e.g., microcystins, cylindrosper-
mopsin), neurotoxins (e.g., anatoxins), dermatotoxins or skin
irritants. Both hepatotoxins and neurotoxins are produced by
cyanobacteria commonly found in surface water and therefore are
of relevance to drinking water supplies [57,10]. Thus, our interest
in this study is to focus on these cyanotoxins (see Table 1). We
believe that the classiﬁcation of cyanotoxins by target organ (i.e.,
hepatotoxins or neurotoxins) is clearly not up to date, given the
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table  1
Cyanotoxins used in this study (abbreviations, molecular formulas, and brief descriptions), which are known to act as hepatotoxins or neurotoxins.
Group of cyanotoxin Name (abbreviation) Chemical and molecular formula Description
Group A Cylindrospermopsin (CYN)
C15H21N5O7S (415.43 g/mol)
CYN is a zwitterionic tricyclic alkaloid produced by a
variety of freshwater cyanobacteria. It is a protein
synthesis inhibitor, may be carcinogenic, and inhibits
pyrimidine nucleotide synthesis. It is classiﬁed as a
cytotoxin and hepatotoxin
Microcystin-LR (MC-LR)
C49H74N10O12 (995.2 g/mol)
MC-LR is a cyclic heptapeptide produced by cyanobacteria.
It is considered to be the most toxic compound of the
microcystin family. It is a tumor promoter and selective
inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A). It
is classiﬁed as a hepatotoxin
Anatoxin-a (ATX-a)
C10H15NO (281.3 g/mol)
ATX-a, also known as Very Fast Death Factor, is a
secondary, bicyclic amine alkaloid and cyanotoxin with
acute neurotoxicity. It was ﬁrst discovered in the early
1960s in Canada, and was isolated in 1972. It is a nicotinic
acetylcholine receptor ligand
Group B -N-methylamino-l-alanine
(BMAA)
C4H10N2O2 (154.60 g/mol)
BMAA is a non-proteinogenic amino acid produced by
cyanobacteria and cycads. It is considered a possible cause
of  ALS/PDC (amyotrophic lateral
sclerosis/parkinsonism–dementia complex) and its
toxicity has been associated with possible chronic
neurodegeneration. It is classiﬁed as a neurotoxin
2,4-Diaminobutyric acid (DAB)
)
DAB is a structural isomer of BMAA and is classiﬁed as a
neurotoxin.
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vailable knowledge on their toxic mechanisms, which are relevant
or several cell types.
The hepatotoxin, microcystin-LR (MC-LR), was  the ﬁrst micro-
ystin chemically identiﬁed and the most studied to date. It has
een associated with most of the incidents of toxicity involving
icrocystins in several countries [10,25]. MC-LR is inhibitor of
rotein phosphatases 1 and 2A, which are present in virtually all
ells and involved in several cell processes including cell division
nd apoptosis, induces sustained phosphorylation of proteins in
ells and DNA damage, and is a potent tumor promoter in chronic
xposures [21,49]. The tricyclic guanidinic alkaloid cylindrosper-
opsin (CYN) is also classiﬁed as a hepatotoxin but has a different
echanism of action, being a protein and glutathione synthesis
nhibitor, with a major impact on liver cells. Indeed, CYN or its
etabolite(s) have been shown in vivo to form adducts in liver
NA in mice [47,20,22]. The binding of cylindrospermopsin or a
etabolite to DNA, and possibly to RNA, in liver cells has been
roposed as a possible mechanism for the inhibition of protein
ynthesis that occurs with cylindrospermopsin toxicity but also in
ther organs such as kidneys, spleen, intestine, thymus and heart
n vertebrates [13,14]. In contrast to neurotoxic alkaloids, CYN acts
ore slowly, taking about 5–6 days to kill mice with a LD50 of
00 g/kg [12]. It has caused serious gastrointestinal and respira-
ory distress through exposure via drinking water in humans and
omestic animals [8,14].In general, the members of the neurotoxin category are not
considered to widespread as hepatotoxins in water supplies, and
they are not considered to pose the same degree of risk from
chronic exposure as microcystins [57]. Anatoxin-a (ATX-a) was  the
ﬁrst cyanotoxin belonging to the class of the neurotoxins to be
characterized [7]. This alkaloid is a potent post-synaptic cholin-
ergic nicotinic agonist and neuromuscular blocking agent that is a
highly toxic nerve poison but has a short biological half-life [12].
The Guideline value (GV) for drinking water was established at
12.24 g/l [18].
-N-methylamino-l-alanine (BMAA) has been detected in sev-
eral resource waterbodies [38] and was the ﬁrst neurotoxin isolated
from cycad trees on Guam in 1967. It may  be involved in multi-
ple neurodegenerative diseases [16] such as amyotrophic lateral
sclerosis/parkinsonism–dementia complex (ALS/PDC) on the Island
of Guam in the East Paciﬁc [3]. BMAA has also been detected in the
brains of Canadian patients with Alzheimer’s disease [41]; how-
ever, others have failed to detect BMAA in brains of patients with
neurodegenerative diseases [39]. BMAA has an structural isomer,
the 2,4-diaminobutyric acid (DAB) which is very similar to the non-
essential amino acid alanine.It is well known that neurodegenerative diseases, such as
Parkinson’s and Alzheimer’s diseases are associated with inﬂam-
mation processes [31]. Inﬂammation is a rapid response of tissue
to injury and is characterized in the acute phase by increased
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Table 2
Tolerable daily intake (TDI), acute toxicity (LD50), and guideline values (GV) in drinking water, for cyanotoxins used in this study.
Cyanotoxin Oral toxicity test g/kg(b.w.)/day TDIf g/kg(b.w.)/day LD50a g/kg(b.w.) Intra-peritoneal mouse GVb g/l drinking water References
CYN NOAEL = 30c (mouse, 90 days) 0.03 200–2100 1 or 15 [22,5]
MC-
LR
NOAELc = 40 (mouse, 13 weeks) 0.04 25 to ∼1000 1 or 1.5 [23,57,27]
LOAELd = 100 (pig, 44 days) 0.067
ATX-a NOAELc = 510 (mouse, 7 weeks) 0.51 250 12.24 [2,18]
BMAA ND ND EC50e about 1 mM (118 g/ml, in cells) ND [55,45]
DAB ND ND ND ND /
a LD50: median lethal dose of a substance, or the amount required to kill 50% of a given test population.
b GV: estimates made by assuming a human body wt  of 60 kg; allocation factor, AF, of 0.8 and daily drinking water consumption, C, of 2 l. A guideline value (GV; g/l
water),  to be used in formulating risk management strategies to strengthen drinking water safety throughout lifetime consumption, can be calculated as: GV = (TDI × body
wt  × AF)/C; where body wt  is assumed to be 60 kg for a human adult and AF is the allocation factor: the proportion of the TDI via drinking water. Because some oral exposure
may  be via food or dietary supplements [13], an AF of 0.8 (80% of total intake) is assumed for drinking water and C = drinking water consumption per day, assumed to be 2 l
for  an adult. It should be noted that the values for GV in Table 2 were taken from the literature and were not calculated from the TDI values. In actual fact, the values for GV
in  the table are very different from those resulting from the use of the formula given above.
c NOAEL: no-observed-adverse-effect-level.
d LOAEL: lowest-observed-adverse-effect-level.
e EC50: effective concentration for 50% of organisms tested. ND: no data.
f TDI: tolerable daily intake is derived by applying an uncertainty factor of 1000 to the NOAEL. ND: no data.
Table 3
Comparison of cyanotoxin concentrations used in our experiment with the GV values presented in Table 2.
Treatment Dose
(M)
Group A (g/L) Group B (g/L) Comparison with GV for CYN,
MC-LR, and ATX-a (see Table 2)
CYN MC-LR ATX-a BMAA DAB
Alone 0.001 0.415 0.995 0.281 0.154 0.191 ≤GV
0.1  41.43 99.52 28.13 15.46 19.11 >GV
10  4154 9952 2813 1546 1911 >GV
Equimolar mixtures 0.001 0.138 0.332 0.094 0.077 0.095 <GV
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RAW246.7 murine macrophage-like cell line has been pre-Mix  A (÷3)
Mix  B (÷2)
0.1 13.8 33.2 
10  1384.8 3317.3 93
lood ﬂow and vascular permeability along with the accumulation
f ﬂuid, leucocytes (monocytes, macrophages), and inﬂammatory
ediators, such as cytokines TNF-, IL-6, IL-1 [24,48]. The high lev-
ls of Tumor necrosis factor alpha (TNF-),  under these conditions,
esult in hypersensitivity reactions following by chronic inﬂam-
ation [33,48]. Recent studies show that the brain can be a key
arget for certain cyanotoxins such as MCs  and BMAA [25,26,42].
heir potential implication in neurodegenerative diseases such as
lzheimer’s disease has been suggested [42].
Given that several cyanotoxins may  be present in drinking water
t the same time, there is no data on their effects in mixtures. The
im of this study was to test the hypothesis that cyanotoxins at
ow doses are neurotoxic when applied in environmentally relevant
ixtures (e.g., BMAA and DAB co-occur in water [19]; microcystin,
TX-a, and CYN producing cyanobacteria co-occur in sources of
rinking water [51]). Thus, we examined cellular viability, apopto-
is and the pro-inﬂammatory effects of each cyanotoxin listed in
able 1, alone or in mixtures. We  hypothesized that these cyanotox-
ns at doses, which we estimated close to those presumed to be safe
between a no-observed-adverse-effect level (NOAEL) and guide-
ine values (GV) in drinking water) will induce a pro-inﬂammatory
esponse in brain and immune cells, when administered in mix-
ure. Until now, NOAEL and GV are available only for MC-LR, CYN
nd ATX-a (see Table 2). In addition, GV for cyanotoxins in drink-
ng water vary among countries and there are insufﬁcient data to
erive a GV for all cyanobacterial toxins [17,5]. The selection of
oses to test was based on both, the presumption that these doses
ill not induce acute cell toxicity (based on available publications
nd below known LD50 values) and/or the concentration close to
he GV (Table 3). Given that GV are derived by application of an
ncertainty factor (usually 1000), we estimated that concentrations
hich vary within a 1000 fold interval above the GV do not exceed
OAEL levels.7.7 9.5 ≥GV
773.0 955.5 >GV
We  used murine macrophage-like RAW264.7, microglial BV-2,
and neuroblastoma N2a cell lines as these cell lines are frequently
used models to study neurotoxicity and brain damage resulting
from inﬂammation [28,54,15].
2. Materials and methods
2.1. Chemicals and reagents
Cyanotoxins used in this work were used alone and in two
mixtures (group A and group B). See Table 1 for chemical formu-
las and for the brief description of each toxin. CYN, MC-LR, and
ATX-a were purchased from Enzo Life Sciences, Inc. (NY, USA).
MC-LR and CYN were dissolved in sterile water to 1 mM.  ATX-a
was dissolved in sterile water to 2.2 mM.  BMAA and DAB were
obtained from Sigma–Aldrich Canada Co. (ON, Canada) and dis-
solved in sterile water to 65 mM.  All solutions were stored at
−80 ◦C until use. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) was  obtained from Sigma–Aldrich Canada
Cie. (ON, Canada). MTT  was  prepared as a 5 mg/ml stock solution
in phosphate-buffered saline (PBS 1X), ﬁltered through a 0.22 m
ﬁlter before use, and diluted to 1 mg/ml  in a serum-containing
medium. Mouse TNF- ELISA assay kit was purchased from Thermo
Fisher Scientiﬁc Company (ON, Canada). Caspase-Glo 3/7Aassay kit
was purchased from Promega Corporation (WI, USA). All other com-
pounds and reagents, were obtained from Wisent, Inc. (QC, Canada).
2.2. Cell culturesviously used to study inﬂammation-induced neurodegeneration,
toxicology, and immunity [31,15]. These cells were maintained in
Dulbecco’s modiﬁed Eagle’s medium (DMEM).
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Fig. 1. Effects of low doses (0.001, 0.1, 10 M)  of cyanotoxins alone or in combination from group A (CYN, MC-LR, ATX-a, Mix  A) and group B (BMAA, DAB, Mix  B) on the
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mean ± SEM) compared to non-treated cells (Control = 100%), n = 12, *p < 0.05 or **p
BV-2 cell line represents immortalised murine microglial cells
hat are often used to study mechanisms of microglial-dependent
euroinﬂammation [28]. These cells were maintained in the
oswell Park Memorial Institute (RPMI-1640) medium.
N2a or Neuro 2A is a mouse neurblastoma-derived cell line that
as been used to study neuronal differentiation, axonal growth
nd signalling pathways [52]. N2a cells were given as a gift by
r. Pavel Gris and were maintained in Dulbecco’s modiﬁed Eagle’s
edium/Ham’s F12 (DMEM/F12).
Culture mediums were supplemented with 10% foetal bovine
erum (FBS), 1% nonessential amino acids (100X), 1% sodium pyru-
ate (100 mM),  1% l-glutamine, and 1% penicillin/streptomycin
100X) before use. All cell lines were kept at 37 ◦C in a 5% CO2
umidiﬁed incubator for 80% of conﬂuence.
.3. Cell treatmentsThe three cell lines were exposed to low doses (0.001, 0.1 and
0 M)  of each cyanotoxin, cited in Table 1, alone or in mix-
ure for various times: 24, 48, and 72 h. We  have combined them
nto two groups: Group A contains CYN, MC-LR, ATX-a and theird by the MTT assay. The results are presented at % of cell viability measurement
01.
equimolar 10 M mixture (Mix A) (e.g., 3.3/3.3/3.3 M);  Group B
includes BMAA, DAB and their 10 M equimolar mixture (Mix B).
Doses of each cyanotoxin in this study were around guideline values
(GV) in drinking water, tolerable daily intake (TDI) or no-observed-
adverse-effect-level (NOAEL) as described in Tables 2 and 3.
2.4. Cell death and apoptotic assessments
2.4.1. Cellular viability
Cellular viability was  performed and quantiﬁed by MTT assay
as previously described [4]. This method measures mitochondrial
enzyme succinate dehydrogenase (SD) activity. Inhibition of SD is
an indicator of cell death. The assay is based on the cleavage of
MTT  into a blue coloured product (formazan) by SD [40]. After cell
treatments, at different times 24, 48, and 72 h, adherent cells were
washed and incubated MTT  for 1 h at 37 ◦C and 0.04 N-hydrochloric
acid-containing isopropanol solution was added to each well. The
optical density (OD) was measured at 570 nm wavelength and the
reference measurement at 720 nm wavelength using a multimode
microplate reader Nanoquant Inﬁnite M200 (Tecan US, Inc., NC,
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esident macrophage-like cells of the central nervous system (CNS) BV-2 cell viabi
t  % of cell viability measurement (mean ± SEM) compared to non-treated cells (Co
SA). Results are presented as % in comparison to the non treated
ells (control = 100%).
.4.2. Apoptotic cell death
Apoptotic cell death was  measured with Caspase-Glo® 3/7 assay
Promega Corporation, WI,  USA). It is a luminescent kit designed
or automated high-throughput screening of caspase-3 and -7
ctivities in puriﬁed enzyme preparations or cultures of adher-
nt or suspension cells [44]. The assay provides a pro-luminescent
aspase-3/7 substrate, which contains the tetrapeptide sequence
EVD. When this substrate is cleaved, amino-luciferin is released,
 substrate of luciferase used in the production of light. The
aspase-Glo® 3/7 bioassay was carried out in 96-well white plates.
ell cultures were exposed for 24 h to different concentrations
f cyanotoxins of Group A or B. Luminescence was  measured at
65 nm using the Nanoquant Inﬁnite M200 microplate luminome-
er reader. Flow cytometry was used to analyses percentage of
poptotic and necrotic cells by annexin V PI staining as previously
escribed [29]. ROS level was evaluated as previously described
30]. Samples were analyzed by ﬂow cytometry using a FACS Cal-
bur. Data were analyzed using FlowJo software.rom group A (CYN, MC-LR, ATX-a, Mix  A) and group B (BMAA, DAB, Mix  B) on the
 various times (24, 48, 72 h) evaluated by the MTT  assay. The results are presented
 100%), n = 12, *p < 0.05 or **p < 0.001.
2.5. Inﬂammation assessment
2.5.1. TNF-  ˛ measurement
TNF- was  measured using an Enzyme Linked ImmunoSorbent
Assay (ELISA) (R&D Systems Inc., MN,  USA) according to manufac-
turer speciﬁcation. Quantitative TNF- protein concentration was
determined in cell culture supernatant of each cell type after 24 h of
exposure with the different doses of cyanotoxins played alone or in
the combination of Group A or Group B. The monoclonal antibody
speciﬁc for mice TNF- had been pre-coated onto a microplate.
Standards, controls and samples are pipetted into the wells and
any TNF- present is bound by the immobilized antibody. After
washing away any unbound substances, an enzyme-linked poly-
clonal antibody speciﬁc for TNF- is added and incubated for 2 h at
room temperature on the shaker. Following a wash to remove any
unbound antibody-enzyme reagent, an enhanced luminal/peroxide
substrate solution is added to the wells and incubated for 20 min
then light is produced in proportion to the amount of TNF- bound
in the initial step. The optical density (OD) was  measured at wave-
length of 450 nm and the reference measurement at wavelength of
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50 nm using a multimode microplate reader Nanoquant Inﬁnite
200.
.6. Statistical analysis
The experiments were repeated four times on independent cell
ultures. All data were presented as the mean ± standard error
f mean (SEM). Statistical analyses were performed using Graph-
ad Software Prism 6.0 (GraphPad Software, CA, USA). Differences
etween groups in comparison with control were analyzed using a
onparametric Mann–Whitney test and one-way ANOVA test. The
ifferences were considered signiﬁcant at p values less than 0.05.
. Results.1. MTT  assay
As shown in Figs. 1–3 , Group A toxins are more toxic than Group
 in all three cell types tested. Group B toxins never reached LD50
ig. 3. Effects of low doses (0.001, 0.1, 10 M)  of cyanotoxins alone or in combination f
urine neuroblastoma N2a cell viability at various times (24, 48, 72 h) evaluated by the M
ompared to non-treated cells (Control = 100%), n = 12, *p < 0.05 or **p < 0.001.orts 3 (2016) 180–189 185
levels of toxicity at any of the treatment times (24, 48 or 72 h).
Among the three Group A toxins, MC-LR and ATX-a never reached
LD50 levels of toxicity, while CYN and equimolar Mix A can reach
LD50 between 0.1 M to 10 M at the different times (24, 48 or
72 h). These doses were 5–500-fold lower than the Tolerable Daily
Intake (TDI) for CYN which is 0.02 g/kg (b.w.)/day. Indeed, 10 M
of CYN or 10 M of Mix  A, which is composed of 3.3 M of each of
the Group A toxins induce almost a total death of RAW264.7 and
BV-2 cells (Figs. 1 and 2).
Treatment with CYN or Mix  A induced cell death of the neurob-
lastoma N2a cell line in a dose and time dependent manner (Fig. 3).
For instance, CYN reached LD50 at 10 M at both 24 h and 48 h,
but at 72 h, even the 0.1 M showed LD50 levels of toxicity. Mix
A (10 M)  reached LD50 only at 72 h. N2a cells were more sensi-
tive to BMAA, DAB and their mixture (Mix B), and to MC-LR and
ATX-a, than RAW264.7 and BV-2 cells. No LD50 level of toxicity
were observed for MC-LR and ATX-a in RAW264.7 and BV-2, while
in N2a at 72 h, we  observed a signiﬁcant decrease in cell viability
with MC-LR and ATX-a, which was similar to CYN at 0.1 M.
rom group A (CYN, MC-LR, ATX-a, Mix  A) and group B (BMAA, DAB, Mix  B) on the
TT assay. The results are presented at % of cell viability measurement (mean ± SEM)
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Fig. 4. Apoptotic effects of the low doses (0.001, 0.1, 10 M)  of cyanotoxins alone or in combination from group A (CYN, MC-LR, ATX-a, Mix  A) and group B (BMAA, DAB, Mix
B)  at 24 h through caspases 3/7 induction in three murine cell lines (RAW264.7, BV-2 and N2a). Apoptosis was tested by the Caspase-Glo® 3/7 assay. The results are presented
in  relative units (RLU) of measurements (mean ± SEM) compared to non-treated cells (control), n = 16, *p < 0.05 or **p  < 0.001.
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cig. 5. Inﬂammatory effects of the low doses (0.001, 0.1, 10 M) of cyanotoxins alo
ix  B) at 24 h on three murine cell lines (RAW264.7, BV-2 and N2a). TNF- protein
as  adjusted to cell viability and shown as mean ± SEM compared to non-treated c
.2. Apoptotic cell death
Fig. 4 shows caspase 3/7 activity in RAW264.7, BV-2 and N2a
ells after exposure to different toxins. Our data demonstrate that
n all cell lines, BMAA, its isomer DAB and their equimolar Mix  B
id not induce apoptosis. In contrast, CYN and Mix  A showed a clear
nduction of caspases, an early sign of apoptosis. RAW264.7 and BV-
 cells, 10 M of CYN or Mix  A, at 24 h, induce signiﬁcant activation
f caspases 3/7 (n = 16, *p < 0.05). In BV-2, the effect of Mix A, which
ontains 3.3 M CYN, was 3–6 fold higher than compared to CYNn combination from group A (CYN, MC-LR, ATX-a, Mix  A) and group B (BMAA, DAB,
tiﬁcation was  measured using ELISA method. TNF- protein concentration (pg/ml)
ontrol), n = 8, *p < 0.05 or **p < 0.001.
(10 M)  alone. Furthermore, N2a cells were more sensitive to ATX-
a and Mix  A as compared to RAW264.7 and BV-2 cells. Indeed, both
CYN at 10 M (n = 16, *p < 0.05) and 10 M of the neurotoxin ATX-a
have apoptotic effects on N2a cells (n = 16, **p  < 0.001). In N2a cells,
Mix A induced apoptosis at both 0.1 M and 10 M (n = 16, *p < 0.05
for both).Fig. 5 shows TNF- levels adjusted for cell viability following
treatment with the toxins for 24 h. BMAA, DAB and Mix B did not
affect TNF- levels. ATX-a signiﬁcantly increased TNF- secretion
only in N2a cells (n = 8, *p < 0.05). CYN signiﬁcantly increased the
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Fig. 6. Cyanotoxins induce necrosis in neuronal cell line.
N2a cell line was  treated with 10 M DAB, 10 M BMAA and Mix  B 10 (DAB + BMAA at 10 M concentration). (A and B) are representative histograms of ﬂow cytometry with
annexin V propidium iodide (PI) of control and Mix  B 10 treated cells respectively. (C) Quantiﬁcation of ﬂow cytometry deﬁning live (black bars), apoptotic (open bars), and
n t of HS
ﬂ  ROS. 
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mecrotic cells (gray bars). (D) Representative western blot showing relative amoun
uorescence after staining with DHR123 that start to ﬂuoresce up on oxidation by
xperiment was  repeated at least 3 times *p < 0.5, n = 3.
NF- levels, in N2a cells (n = 8, *p < 0.05) and in BV-2 cells (n = 8,
*p < 0.001) while Mix  A increased TNF- all these cell lines.
We  observed signiﬁcant increase in cell death in N2a cells that
as not accompanied by increase in caspases activity. Looking
urther into the mode of cell death of N2a cells after cyan-
toxin treatment, we performed ﬂow cytometry experiments using
nnexin V PI staining (Fig. 6A–C). Annexin V binds to posphoser-
ne that ﬂips from intracellular to extracellular space at initiation
f apoptosis. Thus cells in early and late stages of apoptosis will
e labeled with annexin V. PI is a nucleic acid dye that penetrates
ecrotic cells and cells at the late stages of apoptosis. If cells are
ot labelled by either dye they are considered life cells. Results
emonstrate that after treatment with DAB, BMAA or the combi-
ation of these two toxins there is a signiﬁcant decrease in life cells
nd increase in cells that are double positive for annexin V and
I, while single positive annexin V cells remain constant. Looking
urther into the mode of cell death after cyanotoxin treatment, we
erformed western blotting of HSP90 in cell culture supernatants.
he amount of HSP90 in supernatants is indicative of necrosis. Con-
istent with PI staining, we observed signiﬁcantly increased level
f HSP90 in supernatants of N2a cells after all treatments with
yanotoxin (Fig. 6D). Such increases in necrosis can be induced by
ramatic increase in ROS level within the cells. To verify this, we
tained cells with DHR123 dye that starts to ﬂuoresce up on oxi-
ation with ROS. We  observed signiﬁcant induction of ROS after
ll treatments (Fig. 6E,F). Interestingly, there was no difference
etween DAB, BMAA and mix  B 10 treatments in any outcomes
easured (Fig. 6A–F).P90 in the supernatant. (E) is a representative histogram overlay showing level of
(F) Quantiﬁcation of ﬂow cytometry experiment measuring ROS production. Each
4. Discussion
This is the ﬁrst study to test common cyanotoxins for potential
neuroinﬂammatory effects. Our results show that cyanotoxins CYN,
MC-LR and ATX were more toxic than BMAA and its isomer DAB.
In addition, our results suggest that a mixture of CYN, MC-LR and
ATX-a is at least 3–15 fold more potent for the induction of apo-
ptosis and inﬂammation compared to the individual compounds.
Our results show that the cyanotoxins tested in this study at doses
that are considered to be “safe”, induce cell death and inﬂamma-
tion, especially in mixtures, in cultured neurons and glial cells. The
presence of these toxins in the brain has already been reported
and reviewed for MCs  and BMAA [55,25,42]. However, the extrap-
olation of in vitro ﬁndings to in vivo and to human health effects
requires knowledge of the bioavailability, the elimination of these
compounds and must certainly take into account their potential
bioaccumultation, metabolism and time-delayed effects, especially
in the developing brain which lacks blood-brain barrier. To date,
in regards to the majority of cyanotoxins, this knowledge is very
limited [56,25,6].
The murine macrophage-like RAW246.7 cell line has been pro-
posed as in vitro model of neurodegeneration resulting from
inﬂammation [31,15]. BV-2 microglia cells, which are the resi-
dent macrophage-like cells in the central nervous system, have
been used to study neuroinﬂammation [43,28]. Both these cell lines
showed a similar pattern of response to cyanotoxins in our study.
They were more affected by CYN and by the mixture of MC-LR, CYN,
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nd ATX-a, which induced rapid cell death and TNF- production
n survived cells, than by MC-LR and ATX-a alone.
N2a cells were less resistant to MC-LR, CYN, and ATX-a in MMT
ssay, compared to macrophage-like cells. ATX-a alone and the
ixture of cyanotoxins of Group A at dose of 0.1 M,  induced apop-
otic responses which was not observed in macrophage-like cells.
his ﬁnding conﬁrms that ATX-a is a potent neurotoxin in vitro even
t doses much less than established NOAEL, and that neurons are
ore sensitive to the mixture of these cyanotoxins. Although neu-
ons have a limited capacity for cytokine production, our data on
NF- in N2a cells show a signiﬁcant pro-inﬂammatory response to
YN, ATX-a, and to the mixture at 10 M.  Our results show that low
oses of CYN and ATX-a, or their combination are highly relevant
or neurodegeneration.
Recently, it was reported that high concentrations of MC-LR
nd BMAA induce signiﬁcant neuronal apoptosis acting through
nduction of caspase activity, chromatin condensation [26], and
eurodegenerative effects, reminiscent of Alzheimer’s disease type
uman tauopathies [34,42]. For instance, it has been shown
hat MC-LR treated hippocampi showed alterations in proteins
nvolved in the cytoskeleton, neurodegeneration, oxidative stress,
poptosis, and energy metabolism. Three proteins related to neu-
odegenerative disease, septin5, -internexin, and -synuclein,
ere increased by MC-LR exposure [26]. Our data suggest that
C-LR has less potential to induce neurodegeneration.
BMAA, an analog of the amino acid alanine, has been found to
e incorporated into proteins isolated from the brains of patients
ffected by amyotrophic lateral sclerosis [46]. In our study, BMAA,
AB and their combination (Mix B) up to 10 M concentration, do
ot affect TNF- levels or apoptosis mediated by caspases 3/7, but
ncreased cell death by 20% in all cell lines. N2a cells cell death was
ot associated with increased caspase activity suggesting alterna-
ive mode of cell death. Indeed, using ﬂow cytometry, we observed
ncrease amount of necrotic cells after toxin treatment, while apop-
otic cells did not change We  measured necrosis by amount of
SP90, that is normally in the cell, in supernatants. We  observed
ncrease in necrosis in N2A cells after treatment with ether DAB or
AAM, but the effect was not additive, suggesting that both tox-
ns affect the same pathway. Most likely such increases in necrosis
re induced by signiﬁcant induction in ROS production that we
bserved after toxin treatments. Both, BMAA and DAB increase
xidative stress, which leads to necrotic damage in neuronal cells.
or instance, it is reported that BMAA induced the both pathways
n rat cerebellar granule cells [50].
In conclusion, our study suggests that environmentally rele-
ant low doses of cyanotoxins, commonly found in mixture in
rinking water, induce pro-apoptotic and pro-inﬂammatory effects
n macrophage-like and neural cells. These results have potential
mplication for further research on cancer and on neurodegenera-
ive diseases, including Alzheimer’s disease in relation to increasing
ontamination of water bodies and food by cyanotoxins.
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